Aurora Cannabis Inc. (ACB) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to Aurora Cannabis Incorporated's fiscal second quarter 2026 results conference call. All participants will be in a listen-only mode. A question and answer session will follow the formal presentation. The conference is being recorded today, Wednesday, November 5th, 2025. I would now like to turn the conference over to your host, Mona King, Chief Financial Officer of Aurora Cannabis. Please go ahead. Hello, and thank you for joining us. With me is Miguel Martin, Executive Chairman and CEO. Earlier this morning, we filed our financials for the fiscal second quarter 2026 period, ending September 30th, 2025, and issued a news release containing these results. This news release, along with our financial statements and MD&A, is available on our IR website, as well as via CEDAR and EDGAR. We have also posted an investor presentation to our IR website for reference purposes. Our discussion today serves as a reminder that certain matters could constitute forward-looking statements that are subject to risks and uncertainties relating to our future financial or business performance. Actual results could differ materially from those anticipated in those forward-looking statements. Risk factors that may affect actual results are detailed in our annual information form and other periodic filings and registration statements. These documents may similarly be accessed via CEDAR and EDGAR. Following your prepared remarks, we'll conduct a question and answer session with our covering analysts. With that, I'll turn the call over to Miguel. Please go ahead. Thanks, Simona. Aurora's sustained strategic focus on global medical cannabis, the highest margin segment of the industry, combined with exceptional operational execution, has once again delivered standout financ...